University of Cambridge > > Innovation Forum > The Power of Personalised Medicine

The Power of Personalised Medicine

Add to your list(s) Download to your calendar using vCal

  • UserDr Tim Guilliams (Founder & CEO at Healx), Dr Mathew Garnett (Wellcome Trust Sanger Institute), Dr Vincent Plagnol (VP Computational Biology at Inivata), Dr Jean Abraham (Dept. of Oncology, University of Cambridge), Dr Cath Brooksbank (Head of Trainin
  • ClockMonday 06 March 2017, 18:00-21:00
  • HouseWolfson Lecture Theatre, Department of Chemistry, Lensfield Rd, CB2 1EW.

If you have a question about this talk, please contact Innovation Forum Cambridge.

Every day millions of people are taking medicines which are not effective for their specific disease. Some widely used drugs are often truly beneficial only on a small percentage of the population. Personalised medicine aims to develop and prescribe medications that are active on the one-patient, focusing on the single person instead of a large study group. This new frontier of medicine is taking into account genetic and environmental factors among the others, opening new perspectives for cancer and rare diseases as well as widely diffused disorders.

An evening event including talks, a panel discussion and a networking session.

Keynote speakers:
  • Tim Guilliams – Founder & CEO at Healx
  • Mathew Garnett – Wellcome Trust Sanger Institute
  • Vincent Plagnol – VP Computational Biology at Inivata
  • Jean Abraham – Dept. of Oncology, University of Cambridge
  • Cath Brooksbank – Head of Training at EMBL -EBI

Please register at:

This talk is part of the Innovation Forum series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity